Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol in Youth with Opioid Use Disorder
NCT02593474Phase 1Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of naltrexone in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Primary endpoint: Retention in treatment at week 9. Started Sep 2015; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02593474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593474.